PUMA BIOTECHNOLOGY INC
PBYI·74587V107·US·Common Stock·Healthcare - Biotechnology-13D/G
PBYI (PUMA BIOTECHNOLOGY INC) is held by 88 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($23M), RENAISSANCE TECHNOLOGIES LLC ($12.4M), AMERICAN CENTURY COMPANIES INC ($12.2M). Net institutional sentiment: Mixed.
88
Holders
Avg rating(22 Elite)
$168.3M
Total Value
57% (96)
Fund Consensus
47 buying - 36 selling
Who's Trading
InsiderAHAUERBACH ALAN HSell $106KJan 7, 2026
InsiderNFNOUGUES MAXIMO FSell $38KJan 7, 2026
InsiderHMHUNT DOUGLAS MSell $29KJan 7, 2026
InsiderAHAUERBACH ALAN HSell $99KJan 6, 2026
InsiderNFNOUGUES MAXIMO FSell $27KJan 6, 2026
InsiderHMHUNT DOUGLAS MSell $23KJan 6, 2026
InsiderMPMILLER MICHAEL PATRICKSell $97KNov 11, 2025
InsiderCACesano AlessandraSell $91KJul 18, 2025
13F: Insider & Congress:
Showing 1-20 of 96
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer